email@email.com
Request a Call
Contact Online
Subscribe |
| Log In
The most widely read newsletter on China's life science industry.
Toggle navigation
Home
Subscribe
Top Stories
Hot Topics
Search
Conferences
Consulting
About Us
Contact Us
ChinaBio® Today Articles
Welcome to the ChinaBio® Today store. As a service to our readers, we offer access to individual articles for only $5.00 (USD) each. Of course, a subscription is only $20/mo, so you may prefer to subscribe. If so, click on Subscribe in the menu.
Browse
All Products
Articles
All Products
Viewing
3016 - 3030
of 5662 products
View All
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
Next
WuXi AppTec to Acquire Texas-Based Global Clinical Trial CRO
$5.00
Available
Chi-Med/AstraZeneca Drug Shows Efficacy Against Lung Cancer
$5.00
Available
Shenzhen Hepalink Invests $69 Million in Canada's Resverlogix
$5.00
Available
Huawei and Phillips Building AI Healthcare Platform for China
$5.00
Available
CASI Pharma Raises $23 Million in Private Placement
$5.00
Available
Innovent Licenses Use of Harbour Biomed's Biologic Drug Discovery Platform
$5.00
Available
China Biologic to Acquire TianXinFu, a Device Company, in $536 Million Deal
$5.00
Available
Samsung BioLogics' New Plant Approved by FDA
$5.00
Available
Generon Announces SPA for US Phase III Trial of Neutropenia Drug
$5.00
Available
Gentris and Shanghai Institute Sign MOU for Biomarker Collaboration
$5.00
Available
China's State Council Endorses CFDA's New Foreign Clinical Trial Data Policies
$5.00
Available
Shanghai Pharma in Second Round Bidding in $1.5 Billion Cardinal China Deal
$5.00
Available
Beijing is Home to Gates-Backed $100 Million Global Health Institute
$5.00
Available
Zhejiang Huahai Raises $152 Million for New Biopharma Facility
$5.00
Available
Hong Kong's Jacobson Pharma Raises $64 Million for M&A
$5.00
Available